Rachel Thomson-Roberts

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience.

Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 06, 2026

A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors.

A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors.

Journal: Frontiers in oncology

Published: April 30, 2025

Curative or non-curative: immunotherapy for advanced melanoma.

Curative or non-curative: immunotherapy for advanced melanoma.

Journal: JNCI cancer spectrum

Published: January 12, 2025

Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of Australasia.

Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of Australasia.

Journal: Pathology

Published: December 18, 2024

Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.

Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 02, 2024

Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation.

Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 27, 2024

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.

Journal: Journal for immunotherapy of cancer

Published: May 31, 2022

Talimogene laherparepvec resulting in near-complete response in a patient with treatment-refractory Merkel cell carcinoma.

Talimogene laherparepvec resulting in near-complete response in a patient with treatment-refractory Merkel cell carcinoma.

Journal: The Australasian journal of dermatology

Published: March 21, 2022

Targeting Mutated KRAS Genes to Treat Solid Tumours.

Targeting Mutated KRAS Genes to Treat Solid Tumours.

Journal: Molecular diagnosis & therapy

Published: October 17, 2021

Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy.

Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy.

Journal: ANZ journal of surgery

Published: February 23, 2021

A retrospective analysis of eosinophilia as a predictive marker of response and toxicity to cancer immunotherapy.

A retrospective analysis of eosinophilia as a predictive marker of response and toxicity to cancer immunotherapy.

Journal: Future science OA

Published: December 14, 2020

Applying adjuvant therapy for melanoma into clinical practice.

Applying adjuvant therapy for melanoma into clinical practice.

Journal: Expert review of anticancer therapy

Published: October 23, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026